Idiopathic pulmonary fibrosis (IPF) is a complex disease with a highly variable clinical course and generally poor prognosis. Classified as a rare disease, significant increases in incidence have been recorded worldwide in recent years. Left untreated IPF is extremely debilitating with substantial personal, social and economic implications.
The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis / Aiello, Marina; Bertorelli, Giuseppina; Bocchino, Marialuisa; Chetta, Alfredo; Fiore Donati, Alfeo; Fois, Alessandro; Marinari, Stefano; Oggionni, Tiberio; Polla, Biagio; Rosi, Elisabetta; Stanziola, ANNA AGNESE; Varone, Francesco; SANDUZZI ZAMPARELLI, Alessandro. - In: PULMONARY PHARMACOLOGY & THERAPEUTICS. - ISSN 1094-5539. - 44:(2017), pp. 7-15. [10.1016/j.pupt.2017.02.005]
The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis
BOCCHINO, MARIALUISA;STANZIOLA, ANNA AGNESE;SANDUZZI ZAMPARELLI, ALESSANDRO
2017
Abstract
Idiopathic pulmonary fibrosis (IPF) is a complex disease with a highly variable clinical course and generally poor prognosis. Classified as a rare disease, significant increases in incidence have been recorded worldwide in recent years. Left untreated IPF is extremely debilitating with substantial personal, social and economic implications.| File | Dimensione | Formato | |
|---|---|---|---|
|
the earlier the better.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
916.21 kB
Formato
Adobe PDF
|
916.21 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
